COMMUNIQUÉS West-GlobeNewswire

PDC Healthcare Launches New DuraProtect™ Laser Wristbands Engineered to Deliver Greater Durability at a Lower Cost

28/11/2017 - 16:00

VALENCIA, Calif., Nov. 28, 2017 (GLOBE NEWSWIRE) -- PDC Healthcare , a global leader of innovative identification and patient safety solutions, announced today the launch of DuraProtect ™, its newest line of laser [...]

Biothera Pharmaceuticals Enters Cancer Immunotherapy Clinical Trial Collaboration Agreement

28/11/2017 - 15:00

EAGAN, Minn., Nov. 28, 2017 (GLOBE NEWSWIRE) -- Biothera Pharmaceuticals, Inc. today announced that it has entered into a clinical trial collaboration agreement with Genentech, Inc., a member of the Roche Group, to [...]

Chembio Diagnostics Awarded UNICEF Contract to Supply Point-of-Care DPP® Zika Assays and DPP® Micro Readers

28/11/2017 - 14:50

MEDFORD, N.Y., Nov. 28, 2017 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI ), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced that it has been awarded a [...]

ToolGen, Inc. Announces Poster Presentation on CRISPR Technology at 2017 American Society of Hematology Annual Meeting

28/11/2017 - 14:30

SEOUL, South Korea, Nov. 28, 2017 (GLOBE NEWSWIRE) -- ToolGen, Inc. (KONEX, 199800), a biotechnology company specializing in genome editing, today announced a poster presentation on its CRISPR technology at the upcoming [...]

CytomX Therapeutics Announces FDA Acceptance of Investigational New Drug Application for CTLA-4 Probody Therapeutic

28/11/2017 - 14:30

Goal is a safer, more effective version of Yervoy ® Triggers $10 Million Milestone Payment to CytomX from Bristol Myers Squibb NEW YORK and SOUTH SAN FRANCISCO, Calif., Nov. 28, 2017 (GLOBE NEWSWIRE) -- CytomX [...]

Cidara Therapeutics Completes Enrollment in Phase 2 STRIVE Trial Evaluating Novel Antifungal Rezafungin (CD101 IV) in Invasive Fungal Infections

28/11/2017 - 14:30

SAN DIEGO, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX ), a biotechnology company developing novel anti-infectives including immunotherapies, today announced the completion of patient [...]

Catalyst Biosciences Strengthens Clinical Hemophilia Programs with Additions to its Senior Leadership Team

28/11/2017 - 14:30

-- Appoints Arwa Shurrab as Vice President of Regulatory Affairs and Jamie Ellen Siegel, M.D., as Head of Clinical Development -- SOUTH SAN FRANCISCO, Calif., Nov. 28, 2017 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc [...]

Skyline Medical and Helomics Announce a Joint Strategic Partnership with GLG Pharma

28/11/2017 - 14:30

MINNEAPOLIS, Nov. 28, 2017 (GLOBE NEWSWIRE) -- GLG Pharma, a Jupiter, Florida company developing precision medicines that target the Signal Transducer and Activator of Transcription factor 3 (“p-STAT3 and STAT3”) [...]

Peregrine Pharmaceuticals, Ronin Trading and SW Investment Management Announce Settlement Agreement

28/11/2017 - 14:05

TUSTIN, Calif. and CHICAGO, Ill., Nov. 28, 2017 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM ) (NASDAQ: PPHMP ) (“Peregrine”) and Ronin Trading, LLC and SW Investment Management LLC (together, " [...]

Healthwise® Orthopedic Decision Aids Receive Certification From Washington State Health Care Authority

28/11/2017 - 14:00

BOISE, Idaho, Nov. 28, 2017 (GLOBE NEWSWIRE) -- The Washington State Health Care Authority announced the certification of Healthwise decision aids as part of an effort in Washington to put evidence-based information [...]

Insmed to Present at the Nasdaq 37th Annual Investor Conference

28/11/2017 - 14:00

BRIDGEWATER, N.J., Nov. 28, 2017 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq: INSM ), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced that Will Lewis, [...]

CinRx Closes $10 Million Series B Financing

28/11/2017 - 14:00

CINCINNATI, Nov. 28, 2017 (GLOBE NEWSWIRE) -- CinRx, a biopharmaceutical company with an innovative approach to developing novel therapeutics that address diverse therapeutic areas, announced today the completion of its [...]

Argos Provides Financial Update

28/11/2017 - 14:00

DURHAM, N.C., Nov. 28, 2017 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc. (NASDAQ: ARGS ), an immuno-oncology company focused on the development and commercialization of individualized immunotherapies based on the Arcelis [...]

TESARO Announces Availability of VARUBI® (rolapitant) IV for Delayed Nausea and Vomiting Associated With Cancer Chemotherapy in the United States

28/11/2017 - 14:00

VARUBI injectable emulsion features ready-to-use, single-dose vial No saline, reconstitution or mixing is required to utilize VARUBI IV New formulation offers healthcare providers flexibility in their choice of [...]

PhaseBio Enters Worldwide License Agreement with MedImmune for a Reversal Agent for Ticagrelor

28/11/2017 - 14:00

First-in-class and unique reversal agent for ticagrelor aims to address important unmet need for patients requiring antiplatelet therapy Potential for accelerated development timeline with Phase 1 initiation expected in [...]

Provant Vice President of Client Management Elizabeth Merritt, Esq., is featured prominently in a recent Bloomberg Law article on wellness program incentives

28/11/2017 - 14:00

EAST GREENWICH, R.I., Nov. 28, 2017 (GLOBE NEWSWIRE) -- Provant Vice President of Client Management Elizabeth Merritt, Esq., is featured prominently in a recent Bloomberg Law article on wellness program incentives. [...]

Neos Therapeutics to Participate in Two December Conferences

28/11/2017 - 14:00

DALLAS and FORT WORTH, Texas, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS ), a pharmaceutical company focused on developing, manufacturing, and commercializing innovative extended-release (XR [...]

Athenex Announces Acceptance of Phase II Data of KX2-391 for the Treatment of Actinic Keratosis for Presentation at the American Academy of Dermatology Meeting on February 17, 2018

28/11/2017 - 14:00

BUFFALO, N.Y., Nov. 28, 2017 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX ), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]

Zogenix To Host Call with Pediatric Epilepsy Expert Joseph Sullivan, M.D., on Dravet Syndrome and ZX008 on Monday, December 4

28/11/2017 - 14:00

EMERYVILLE, Calif., Nov. 28, 2017 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX ), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) disorders, today announced that [...]